Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a Four-Week online therapy program tame menopause hot flashes?

NCT ID NCT07873177

Symptom relief Sponsor: St. Joseph's Healthcare Hamilton Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Oct 14, 2026 · Last updated Oct 21, 2026 · Updated 3 times

Summary

Researchers are testing a four-week, therapist-guided online cognitive behavioural therapy program for menopausal hot flashes and night sweats. The pilot trial enrolls 50 women and individuals assigned female at birth, aged 40 to 65, in Canada. Participants complete weekly online lessons, brief guide meetings, and questionnaires. The study compares those who start the program right away with those who wait four weeks, and it measures whether the program is practical and acceptable, and whether it may ease symptoms, sleep, mood, and quality of life.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Internet-delivered cognitive behavioural therapy (ICBT-Meno-VS)
What this could lead to
If the program proves feasible and acceptable, it could offer a low-cost, at-home way to manage hot flashes and night sweats, especially for people who cannot access in-person care.
What could go wrong
This is a small pilot study of 50 people, so it may not show clear symptom relief or generalise to all menopausal individuals. Online therapy also requires reliable internet and may not suit everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 50 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Oct 2026

An estimate. Start dates often move.

Expected to finish

Aug 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

40 to 60 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * women and individuals assigned female at birth (AFAB) aged 40-65 years of age; * subjective distressing vasomotor symptoms (a score of 30 or higher on the Hot Flash Rating Scale); * residing in Canada; * fluent in English; * access to, and comfort with, the internet and a computer; * not currently engaged in psychotherapy; * not taking hormonal or psychotropic medication or if taking medication, stable in type and dose for 8 weeks prior to study and stable for duration of the study Exclusion Criteria: * participants with severe depression (as a score of 15 and over on the PHQ-9 or active suicidal ideation or psychotic symptoms; * participants with a severe mental health disorder requiring in-person therapy (e.g., severe substance abuse, recent history of psychosis or mania); * participants with an unstable general medical condition; * participants with cognitive impairment that would limit comprehension or ability to engage with the online program.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Menopausal vasomotor symptoms are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Hot Flashes

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Menopausal vasomotor symptoms Menopause

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • St. Joseph's Healthcare Hamilton

    Hamilton, Ontario, L8P 3R2, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.